Joel Greenblatt’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.2M | Buy |
381,851
+6,007
| +2% | +$791K | 0.11% | 196 |
|
|
2026
Q1 | $52.4M | Buy |
375,844
+76,712
| +26% | +$10.7M | 0.16% | 90 |
|
|
2025
Q4 | $36.7M | Sell |
299,132
-46,765
| -14% | -$5.68M | 0.13% | 151 |
|
|
2025
Q3 | $38.4M | Buy |
345,897
+63,701
| +23% | +$7.24M | 0.17% | 85 |
|
|
2025
Q2 | $31.3M | Buy |
282,196
+31,202
| +12% | +$3.32M | 0.19% | 61 |
|
|
2025
Q1 | $28.1M | Sell |
250,994
-5,047
| -2% | -$521K | 0.23% | 29 |
|
|
2024
Q4 | $23.7M | Buy |
256,041
+873
| +0.3% | +$78.6K | 0.22% | 46 |
|
|
2024
Q3 | $21.4M | Sell |
255,168
-26,284
| -9% | -$2.01M | 0.22% | 47 |
|
|
2024
Q2 | $19.3M | Buy |
281,452
+133,164
| +90% | +$8.89M | 0.25% | 36 |
|
|
2024
Q1 | $10.9M | Buy |
148,288
+52,866
| +55% | +$4.07M | 0.16% | 121 |
|
|
2023
Q4 | $7.73M | Sell |
95,422
-84,227
| -47% | -$6.55M | 0.14% | 154 |
|
|
2023
Q3 | $13.5M | Buy |
179,649
+68,646
| +62% | +$5.28M | 0.28% | 34 |
|
|
2023
Q2 | $8.56M | Buy |
111,003
+11,277
| +11% | +$899K | 0.19% | 94 |
|
|
2023
Q1 | $8.27M | Buy |
99,726
+20,404
| +26% | +$1.69M | 0.2% | 84 |
|
|
2022
Q4 | $6.81M | Buy |
79,322
+345
| +0.4% | +$27.3K | 0.19% | 103 |
|
|
2022
Q3 | $4.87M | Sell |
78,977
-13,887
| -15% | -$876K | 0.15% | 161 |
|
|
2022
Q2 | $5.74M | Sell |
92,864
-10,651
| -10% | -$659K | 0.18% | 127 |
|
|
2022
Q1 | $6.15M | Buy |
103,515
+18,160
| +21% | +$1.16M | 0.19% | 133 |
|
|
2021
Q4 | $6.2M | Sell |
85,355
-31,662
| -27% | -$2.18M | 0.2% | 117 |
|
|
2021
Q3 | $8.17M | Buy |
117,017
+24,187
| +26% | +$1.7M | 0.33% | 61 |
|
|
2021
Q2 | $6.39M | Sell |
92,830
-9,504
| -9% | -$635K | 0.27% | 96 |
|
|
2021
Q1 | $6.61M | Sell |
102,334
-45,359
| -31% | -$2.92M | 0.3% | 84 |
|
|
2020
Q4 | $8.61M | Buy |
147,693
+81,414
| +123% | +$4.91M | 0.28% | 97 |
|
|
2020
Q3 | $4.19M | Sell |
66,279
-25,000
| -27% | -$1.73M | 0.13% | 210 |
|
|
2020
Q2 | $7.02M | Sell |
91,279
-65,368
| -42% | -$5.01M | 0.21% | 124 |
|
|
2020
Q1 | $11.7M | Sell |
156,647
-94,403
| -38% | -$6.52M | 0.33% | 74 |
|
|
2019
Q4 | $16.3M | Sell |
251,050
-211,763
| -46% | -$13.8M | 0.3% | 89 |
|
|
2019
Q3 | $29.3M | Buy |
462,813
+178,621
| +63% | +$11.7M | 0.52% | 40 |
|
|
2019
Q2 | $19.2M | Buy |
284,192
+44,776
| +19% | +$2.95M | 0.31% | 87 |
|
|
2019
Q1 | $15.6M | Sell |
239,416
-314,073
| -57% | -$20.9M | 0.23% | 125 |
|
|
2018
Q4 | $34.6M | Buy |
553,489
+193,250
| +54% | +$13.5M | 0.54% | 31 |
|
|
2018
Q3 | $27.8M | Sell |
360,239
-56,012
| -13% | -$4.23M | 0.38% | 67 |
|
|
2018
Q2 | $29.5M | Sell |
416,251
-121,051
| -23% | -$8.55M | 0.43% | 56 |
|
|
2018
Q1 | $40.5M | Sell |
537,302
-127,490
| -19% | -$10.1M | 0.57% | 29 |
|
|
2017
Q4 | $47.6M | Sell |
664,792
-31,830
| -5% | -$2.42M | 0.69% | 17 |
|
|
2017
Q3 | $56.4M | Sell |
696,622
-267,099
| -28% | -$20.4M | 0.83% | 8 |
|
|
2017
Q2 | $68.2M | Sell |
963,721
-248,315
| -20% | -$16.5M | 0.96% | 1 |
|
|
2017
Q1 | $82.3M | Buy |
1,212,036
+186,833
| +18% | +$13.1M | 1.05% | 3 |
|
|
2016
Q4 | $73.4M | Buy |
1,025,203
+101,669
| +11% | +$7.56M | 0.95% | 4 |
|
|
2016
Q3 | $73.1M | Sell |
923,534
-92,608
| -9% | -$7.52M | 0.95% | 5 |
|
|
2016
Q2 | $84.8M | Buy |
1,016,142
+48,500
| +5% | +$4.3M | 1.02% | 2 |
|
|
2016
Q1 | $88.9M | Buy |
967,642
+93,396
| +11% | +$8.42M | 1% | 1 |
|
|
2015
Q4 | $88.5M | Sell |
874,246
-62,736
| -7% | -$6.53M | 0.96% | 1 |
|
|
2015
Q3 | $92M | Sell |
936,982
-131,146
| -12% | -$14.6M | 0.9% | 2 |
|
|
2015
Q2 | $125M | Sell |
1,068,128
-39,604
| -4% | -$4.33M | 1.05% | 1 |
|
|
2015
Q1 | $109M | Buy |
1,107,732
+98,270
| +10% | +$9.98M | 0.83% | 1 |
|
|
2014
Q4 | $95.2M | Buy |
1,009,462
+345,239
| +52% | +$35.7M | 0.77% | 2 |
|
|
2014
Q3 | $70.7M | Buy |
664,223
+197,370
| +42% | +$19.3M | 0.7% | 5 |
|
|
2014
Q2 | $38.7M | Buy |
+466,853
| New | +$36.3M | 0.48% | 34 |
|
Other funds holding GILD
Joel Greenblatt's GILD Position: Q2 2026 in Review
Joel Greenblatt increased its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, buying an estimated $791K and bringing the position to 381,851 shares worth $48.2M. The position accounts for 0.11% of the portfolio, ranked #196.
Joel Greenblatt first reported a position in GILD in Q2 2014 and has held it in 49 quarters since. The position peaked at $125M in Q2 2015. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Joel Greenblatt held 381,851 shares of Gilead Sciences worth $48.2M as of Q2 2026.
- Joel Greenblatt bought 6,007 Gilead Sciences shares in Q2 2026, an estimated $791K.
- Gilead Sciences made up 0.11% of Joel Greenblatt's portfolio in Q2 2026, its #196 holding.
- Joel Greenblatt first reported a position in Gilead Sciences in Q2 2014 and has held it in 49 quarters since.
- Joel Greenblatt's Gilead Sciences position peaked at $125M in Q2 2015.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.